Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma-Reference-Cited by-同舟云学术

Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma

Published:2020-06-21 Issue:7 Volume:111 Page:2570-2578
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sato Tomonori¹^ORCID,Kawasaki Yoshihide¹,Maekawa Masamitsu²,Takasaki Shinya²,Shimada Shuichi¹,Morozumi Kento¹,Sato Masahiko¹,Kawamorita Naoki¹,Yamashita Shinichi¹,Mitsuzuka Koji¹,Mano Nariyasu²,Ito Akihiro¹

Affiliation:

1. Department of Urology Tohoku University Graduate School of Medicine Sendai Japan

2. Department of Pharmaceutical Sciences Tohoku University Hospital Sendai Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14440

Reference34 articles.

1. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma

2. Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker Discovery

3. Cancer metabolism in space and time: Beyond the Warburg effect

4. Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC

5. Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy for renal cell carcinoma;Clinica Chimica Acta;2024-09

2. Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort;iScience;2024-07

3. Analysis of Metabolic Changes in Endogenous Metabolites and Diagnostic Biomarkers for Various Diseases Using Liquid Chromatography and Mass Spectrometry;Biological and Pharmaceutical Bulletin;2024-06-01

4. Elucidation and Regulation of Tyrosine Kinase Inhibitor Resistance in Renal Cell Carcinoma Cells from the Perspective of Glutamine Metabolism;Metabolites;2024-03-19

5. Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring;Frontiers in Oncology;2024-02-07